paper-with-me

Papers

Generating Developable 3D Molecules via Pocket-Conditioned Diffusion and Property-Aware Optimization

2026-07-14 · Ruoxi Gao, Jiangweizhi Peng, Ziqi Chen, Frazier N. Baker, David C. Kombo, John L. Kane, Andrew A. Scholte, Yi Li, Matthew J. LaMarche, Luigi I. Iconaru, Hans-Peter Biemann, Mingyi Hong, Xia Ning arxiv

Drug discovery and development is time-consuming and resource-intensive, motivating computational approaches such as diffusion models for de novo drug design. Many such models follow the structure-based drug design (SBDD) paradigm, generating molecules to fit a target binding pocket. However, existing diffusion-based SBDD methods typically couple pocket and ligand representation learning, model interactions only at the atom level, and prioritize binding affinity over other developability properties. Here, we introduce conDitar-dev, a conditional diffusion-based SBDD framework for generating ligands with strong binding affinities and favorable ADMET properties. It consists of three modules: msPRL, a pretrained multi-scale pocket representation learning module; conDitar, a pocket-conditioned diffusion model guided by msPRL representations; and paOPT, a generation-time method for optimizing ligand developability. On a newly curated benchmark of human disease targets, conDitar outperforms state-of-the-art SBDD baselines, achieving an average binding score of -8.85 kcal/mol. Across five ADMET properties, conDitar-dev improves performance by up to 73% over conDitar. To further validate the abilities of conDitar-dev to generate developable molecules, we have applied it to two validated druggable targets: programmed death-ligand 1 (PD-L1) and colony-stimulating factor 1 receptor (CSF1R) proteins. Top-ranked generatively designed molecules and their analogs have been experimentally synthesized and biologically tested. Two molecules generated directly by conDitar-dev for PD-L1 exhibited SPR-derived $K_D$ values of 3.49 and 3.75 $μ$M, respectively. Hit expansion based on conDitar-dev-designed molecules identified selective CSF1R inhibitors with IC$_{50}$ values as low as 200 nM, while also uncovering opportunities for drug repositioning.

📄 PDF Abstract BibTeX arXiv:2607.12349

Code (2)

Tavish9/awesome-daily-AI-arxiv ★ 111
arxivsub/arXivSub_daily_arxiv ★ 3

Tasks

Representation LearningDrug Discovery

Similar Papers 제목 키워드 기반

Autoregressive fragment-based diffusion for pocket-aware ligand design

2023-12-15 · Mahdi Ghorbani, Leo Gendelev, Paul Beroza, Michael J. Keiser

In this work, we introduce AutoFragDiff, a fragment-based autoregressive diffusion model for generating 3D molecular structures conditioned on target protein structures. We employ geometric vector perceptrons to predict …

NEAT-POCKET: Pocket-Conditioned Autoregressive 3D Molecular Generation with a Neighborhood-Guided Set Transformer

2026-09-04 · Roxane Axel Jacob, Daniel Rose, Thierry Langer, Johannes Kirchmair arxiv

AI-driven de novo molecular design offers a promising route to accelerate early-stage drug discovery by generating novel ligands directly within target protein binding pockets. We present NEAT-POCKET, a pocket-conditione…

Drug Discovery

Learning Subpocket Prototypes for Generalizable Structure-based Drug Design

2023-05-22 · Zaixi Zhang, Qi Liu

Generating molecules with high binding affinities to target proteins (a.k.a. structure-based drug design) is a fundamental and challenging task in drug discovery. Recently, deep generative models have achieved remarkable…

3D Molecule GenerationDrug DesignDrug Discovery

Peptide2Mol: A Diffusion Model for Generating Small Molecules as Peptide Mimics for Targeted Protein Binding

2025-11-07 · Xinheng He, Yijia Zhang, Haowei Lin, Xingang Peng 외 arxiv

Structure-based drug design has seen significant advancements with the integration of artificial intelligence (AI), particularly in the generation of hit and lead compounds. However, most AI-driven approaches neglect the…

Graph Neural Network

Do Language Models Dream of Binding Molecules? Benchmarking LLMs under Spatial Constraints

2026-07-20 · Thomas MacDougall, Maksim Kuznetsov, Roman Schutski, Rim Shayakhmetov 외 hf

Structure-based drug design (SBDD) leverages the 3D structure of protein targets, often complemented by other spatial constraints, to generate candidate binding molecules. While diffusion models have dominated as a leadi…